Withings ScanWatch is available today in Europe, priced at €280/£250 in for the 38mm edition and €299/£280 for the 42mm body.
Right now, this is the furthest a hybrid watch can go when it comes to health sensors until we see a quantum leap in technology.
It packs ECG and SpO2 sensors alongside the usual tools you'd expect from a Withings hybrid.
Withings says that the ScanWatch’s battery will last for up to 30 days on a charge, and it comes with a pogo-pin charging plate in the case.
Work is being done on ways of using optical sensors to monitor blood sugar or food intake, but that’s nowhere near ready for prime time.
Naturally, all Withings products lean heavily on Health Mate, one of the better health companion apps available.
The lower one is the patented analog activity dial that features on every Withings hybrid.
I think it’s more elegant and reliable than the Move ECG, which required you to pinch the watch face on both sides like a battery tester.
The second sundial, up top, is the rounded PMOLED display that will show you smart notifications and let you access the watch’s special features.
The ScanWatch offers a built-in ECG and SpO2 (blood oxygenation) sensors.
For both case sizes, you can opt for a white or black face, although the 42mm black model has a red subdial hand.
It breaks down your health into a daily dashboard and collates your longer-term data to give you a wide-ranging picture of your progress (or lack thereof) over time.
The larger, 42mm model is wonderfully austere, with thick lugs and a subtle beveled edge.
Push the crown in, and you can cycle through menus that show your heart rate, steps taken, distance traveled and floors climbed.
Withings’ latest smartwatch is the first to offer a complete suite of health-monitoring tools inside a watch.
As I wrote last year, there aren’t very many fitness tracking technologies that you can cram into a watch.
This means it can monitor for atrial fibrillation and sleep apnea, two subtle but often impactful health conditions.